Structure-function studies of T-cell receptor-superantigen interactions

Immunological Reviews

Volumn 163, Issue , 1998, Pages 177-186

  Li, Hongmin ^a   Llera, Andrea ^a   Mariuzza, Roy A ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; COMPLEMENTARITY DETERMINING REGION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KINETICS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STRUCTURE-ACTIVITY RELATIONSHIP; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0031816533     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01196.x     Document Type: Article

References (52)

1. Bentley GA, Mariuzza RA. The structure of the T cell antigen receptor. Annu Rev Immunol 1996;14:563-590.
2. Wilson IA, Garcia KC. T-cell receptor structure and TCR complexes. Curr Opin Struct Biol 1997;7:839-848.
3. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-711.
4. Kotzin BL, Leung DYM, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993;54:99-166.
5. Webb SR, Gascoigne NRJ. T cell activation by superantigens. Curr Opin Immunol 1994;6:467-475.
6. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990;17:251-272.
7. Vath GM, et al. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 1997;36:1559-1566.
8. Cole BC, Griffiths MM. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum 1993;36:994-1002.
9. Ito Y, Abe J, Yoshino K, Takeda T, Koshaka T. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein. J Immunol 1995;134:5896-5906.
10. Miyoshi-Akiyama T, Abe A, Kato H, Kawahara K, Narimatsu H, Uchiyama T. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM. J Immunol 1995;154:5228-5234.
11. Paliard X, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1992;253:325-329.
12. Conrad B, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994;371:351-355.
13. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997;90:303-313.
14. Bentley GA, Boulot G, Karjalainen K, Mariuzza RA. Crystal structure of the β chain of a T cell antigen receptor. Science 1995;267:1984-1987.
15. Malchiodi EL, et al. Superantigen binding to a T cell receptor β chain of known three-dimensional structure. J Exp Med 1995;182:1833-1845.
16. Fields BA, et al. Crystal structure of the β chain of a T-cell receptor complexed with a superantigen. Nature 1996;384:188-192.
17. Leder L, et al. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor β chain and major histocompatibility complex class II. J Exp Med 1998;187:823-833.
18. Corr M, et al. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 1994;265:946-948.
19. k complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA 1994;91: 12862-12866.
20. Alam SM, et al. T-cell receptor affinity and thymocyte positive selection. Nature 1996;381:616-620.
21. van der Merwe PA, Brown MH, Davis SJ, Barclay AN. Affinity and kinetics of the interaction of the cell adhesion molecules rat CD2 and CD48. EMBO J 1993;12:4945-4954.
22. van der Merwe PA, et al. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 1994;33:10149-10160.
23. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-151.
24. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-106.
25. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996;384:134-141.
26. Ciurli C, Posnett DN, Sekaly R-P, Denis F. Highly biased CDR3 usage in restricted sets of β chain variable regions during viral superantigen 9 response. J Exp Med 1998;187:253-258.
27. Hodtsev AS, Choi Y, Spanopoulou E, Posnett DN. Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor. J Exp Med 1998;187:319-327.
28. Hong S-C, Waterbury G, Janeway CA Jr. Different superantigens interact with distinct sites in the Vβ domain of a single T cell receptor. J Exp Med 1996;183:1437-1446.
29. Swaminathan S, Furey W, Pletcher J, Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 1992;359:801-806.
30. Papageorgiou A, Acharya KR, Shapiro R, Passalacqua EF, Brehm RD, Tranter HS. Crystal structure of the superantigen enterotoxin C2 from Stapylococcus aureus reveals a zinc-binding site. Structure 1995;3:769-779.
31. b. Science 1992;257:919-927.
32. Housset D, Mazza G, Gregoire C, Piras C, Malissen B, Fontecilla-Camps JC. The three-dimensional structure of a T-cell antigen receptor VαVβ heterodimer reveals a novel arrangement of the Vβ domain. EMBO J 1997;16:4205-4216.
33. Garcia KC, et al. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 1996;274:209-219.
34. Wang J, et al. Atomic structure of an αβ T cell receptor (TCR) heterodimer in complex with an anti-TCR Fab fragment derived from a mitogenic antibody. EMBO J 1997;17:10-26.
35. Garcia KC, et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 1998;279:1166-1172.
36. Jardetzky TS, et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994;368:711-718.
37. Reich Z, Boniface JJ, Lyons DS, Borochov N, Wachtel EJ, Davis MM. Ligand-specific oligomerization of T-cell receptor molecules. Nature 1997;387:617-620.
38. Matsui K, Boniface JJ, Reahy PA, Schild H, Fazekas De St. Groth B, Davis MM. Low affinity interaction of MHC-peptide complexes with T cell receptors. Science 1991;254:1788-1791.
39. Woodland DL, Blackman MA. How do T cell receptors, MHC molecules and superantigens get together? Immunol Today 1993;14:208-212.
40. Labrecque N, Thibodeau J, Mourad W, Sekaly R-P. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. J Exp Med 1994;180:1921-1929.
41. Deckhut AM, Chien Y, Blackman MA, Woodland DL. Evidence for a functional interaction between the β chain of major histocompatibility complex class II and the T cell receptor α chain during recognition of a bacterial superantigen. J Exp Med 1994;180:1931-1935.
42. Daly K, Nguyen P, Hankley D, Zhang WJ, Woodland DL, Blackman MA. Contribution of the TCR α-chain to the differential recognition of bacterial and viral superantigens. J Immunol 1995;155:27-34.
43. Borrero H, Donson D, Cervera C, Rexer C, Macphail S. T cell receptor Vα4 is expressed by a subpopulation of Vβ6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B. J Immunol 1995;154:4247-4260.
44. Donson D, Borrero H, Rutman M, Pergolizzi R, Malhado N, Macphail S. Gene transfer directly demonstrates a role for TCR Vα elements in superantigen recognition. J Immunol 1997;158:5229-5236.
45. Li H, Lebedeva MI, Ward ES, Mariuzza RA. Dual conformations of a T cell receptor Vα homodimer: implications for variability in VαVβ domain association. J Mol Biol 1997;269:385-394.
46. Kim J, Urban RG, Strominger JL, Wiley DC. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility complex molecule, HLA-DR1. Science 1995;266:1870-1874.
47. Dall'Acqua W, Goldman ER, Eisenstein E, Mariuzza RA. A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry 1996;35:9667-9676.
48. Goldman ER, Dall'Acqua W, Braden BC, Mariuzza RA. Analysis of binding interactions in an idiotope-anti-idiotope protein-protein complex using double mutant cycles. Biochemistry 1997;36:49-56.
49. Clackson T, Wells JA. A hot spot of binding energy in a hormone-receptor interface. Science 1995;267:383-386.
50. Dall'Acqua W, et al. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry 1998 (In press).
51. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 1996;14:1-27.
52. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM. Kinetic discrimination in T-cell activation. Proc Natl Acad Sci USA 1996;93:1401-1405.